Cardiovascular Diseases

Patient-Reported Outcomes Similar with Intensive BP Target

Patient-reported outcomes among participants who received intensive BP treatment were similar to those among participants who received standard treatment. A total of 9361 participants with hypertension at high risk for cardiovascular disease were randomly assigned to a systolic blood-pressure (SBP) target of less than 120 mm Hg or 140 mm Hg. Participants who received intensive treatment received an average of one additional antihypertensive medication, and the SBP was 14.8 mm Hg lower in the group that received intensive treatment than in the group that received standard treatment. There were no significant differences in physical, mental and psychological scores, satisfaction and adherence between the two groups. The intensive treatment was also cost-effective. Source: http://www.nejm.org/

hyangiu

Recent Posts

SGLT2 Inhibitors Tied to Lower Risk in Patients with Diabetes and Cirrhosis

A rigorous cohort study utilizing Taiwan’s National Health Insurance Database provides robust evidence that SGLT2…

19 hours ago

Lobar and Mixed Cerebral Microbleeds Linked to Increased Dementia Risk

A new study investigating the link between cerebral microbleeds (CMBs) and dementia has found that…

4 days ago

DASH Diet Best for Long-Term Brain Health

A comprehensive prospective study tracking over 159,000 adults for up to three decades has provided…

1 week ago

Intermittent Fasting Shows No Clear Advantage Over Traditional Diets for Weight Loss

A comprehensive new Cochrane review of 22 studies involving nearly 2,000 participants over six months…

2 weeks ago

Healthy Dietary Patterns Linked to Better Life Expectancy

A large-scale study involving 103,649 UK Biobank participants has revealed that adhering to healthy dietary…

3 weeks ago

Statin Adverse Effects Analysis: Separating Signal from Noise

To address uncertainties in statin safety profiles, which are often based on observational data susceptible…

3 weeks ago

This website uses cookies.